Fibrocell Science, Inc. announced that John Maslowski has been appointed Chief Executive Officer and Douglas Swirsky has been appointed Chairman of the Company's Board of Directors, succeeding David Pernock effective immediately. In addition, Mr. Maslowski has been appointed to the Company's Board. Mr. Maslowski joined Fibrocell in 2005 and most recently served as the Company's Senior Vice President of Scientific Affairs with oversight of research and development, clinical and regulatory affairs.

Previously, he was Vice President of Operations with responsibility for manufacturing and quality operations.